OIP5 and hepatocellular carcinoma: miR-15b-5p inhibits OIP5, an oncogenic protein regulating cell cycle progression, which was found to be upregulated in HCC (Li et al., 2017) and is considered to be a biomarker for diagnosis of HCC (Chen et al., 2015).